ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
25.61
-0.26 (-1.01%)
At close: Aug 3, 2026, 4:00 PM EDT
25.29
-0.32 (-1.25%)
After-hours: Aug 3, 2026, 7:34 PM EDT
ACADIA Pharmaceuticals Employees
As of December 31, 2025, ACADIA Pharmaceuticals had 798 total employees, including 796 full-time and 2 part-time employees. The number of employees increased by 144 or 22.02% compared to the previous year.
Employees
798
Change (1Y)
144
Growth (1Y)
22.02%
Revenue / Employee
$1,372,494
Profits / Employee
$470,739
Market Cap
4.39B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Travere Therapeutics | 497 |
| CRISPR Therapeutics AG | 393 |
| Dyne Therapeutics | 263 |
| Relay Therapeutics | 193 |
| Celcuity | 155 |
| Edgewise Therapeutics | 154 |
| Parabilis Medicines | 145 |
ACAD News
- 4 days ago - Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference - Business Wire
- 13 days ago - Acadia Pharmaceuticals price target raised to $36 from $34 at BMO Capital - TheFly
- 13 days ago - Acadia Pharmaceuticals price target raised to $25 from $24 at Stifel - TheFly
- 14 days ago - Acadia Pharmaceuticals price target raised to $25 from $24 at Stifel - TheFly
- 14 days ago - Acadia Pharmaceuticals receives FDA Fast Track designation for remlifanserin - TheFly
- 14 days ago - Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis - Business Wire
- 19 days ago - Acadia Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 4, 2026 - Business Wire
- 27 days ago - Acadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital - TheFly